Monday, August 31, 2015

Scientific and industrial challenges of developing nanoparticle based theranostics and multiple-modality contrast agents for clinical application

Nanoscale, 2015, Accepted Manuscript
DOI: 10.1039/C5NR03887A, Opinion
Yixiang J Wang, Jean-Marc Idee, Claire Corot
Designing of theranostics and dual or multi-modality contrast agents are currently two of the hottest topics in biotechnology and biomaterial science. However, for single entity theranostics, a right ratio of...
The content of this RSS Feed (c) The Royal Society of Chemistry


Click for full article

No comments:

Post a Comment